Results 91 to 100 of about 2,161,716 (285)

Safe beats down under: investigating the support of drug checking at a regional festival in the Northern Territory, Australia

open access: yes
Background In the context of Australian music festivals, including those in the Northern Territory (NT), drug-related harms persist. This study focused on gathering local insights into drug-related behaviours and attitudes, particularly regarding drug ...
Clifford, Sarah   +23 more
core   +1 more source

MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru   +13 more
wiley   +1 more source

Factors associated with drug checking service utilization among people who use drugs in a Canadian setting

open access: yesHarm Reduction Journal, 2020
Background The United States and Canada are amidst an opioid overdose crisis, with the Canadian province of British Columbia (BC) among the hardest hit. In response, drug checking services (DCS) have been introduced in this setting as a novel pilot harm ...
Viseth Long   +9 more
doaj   +1 more source

Control-flow checking via regular expressions [PDF]

open access: yes, 2001
The present paper explains a new approach to program control flow checking. The check has been inserted at source-code level using a signature methodology based on regular expressions.
Di Natale, Giorgio   +9 more
core   +1 more source

Evaluation of Digital Technologies for Home‐Based Assessment in People With Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller   +14 more
wiley   +1 more source

How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives

open access: yesHarm Reduction Journal
Background Mortality related to opioid overdose in the U.S. has risen sharply in the past decade. In California, opioid overdose death rates more than tripled from 2018 to 2021, and deaths from synthetic opioids such as fentanyl increased more than seven
Lissa Moran   +6 more
doaj   +1 more source

Baseline Neuroinflammation Stratifies TSPO‐PET Response to Disease‐Modifying Therapy in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch   +5 more
wiley   +1 more source

Outlook Pamphlet December, 1955

open access: yes, 1955
The Advertising Checking Bureau's month employee publication, Outlook, from December ...
Advertising Checking Bureau
core  

Drug checking service: good practice standards. [PDF]

open access: yes, 2012
NEWIP’s Good Practice Standards are the result of developing the already existing European Drug Prevention Quality Standards further by consulting harm reduction experts and using relevant real-life experiences.
Martins, Daniel   +9 more
core  

Natural Frequencies of Levodopa‐Induced Dyskinesia in Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited.
Ioannis U. Isaias   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy